National Certified Addiction Counselor, Level I (NCAC I) Practice Exam 2026 – Comprehensive All-in-One Guide to Exam Success!

The combination of fluoxetine and sertraline is associated with an increased risk of hyperthermia when used with MDMA due to the potential for serotonin syndrome, a serious condition that can arise when there is an excessive accumulation of serotonin in the brain. Both fluoxetine and sertraline are selective serotonin reuptake inhibitors (SSRIs) that increase serotonin levels in the body. When MDMA is introduced, which also enhances serotonin release, the combined effects can lead to dangerously high serotonin levels, resulting in symptoms such as hyperthermia, agitation, and confusion.

Understanding the pharmacological interactions is critical in addiction counseling, especially since clients may not disclose all substances they are using. Recognizing the risks associated with combinations like SSRIs and MDMA allows counselors to educate clients on safer practices and the importance of disclosing all medications and substances used.